Connecticut Won 60 Days of Medicaid Before Release. It Asked for 90.
CMS approved Connecticut's reentry waiver: Medicaid coverage 60 days before release, not the 90 days the state requested. Residential SUD money continues.

Connecticut can start billing Medicaid for health care delivered inside its prisons and jails up to 60 days before a person is released, under a federal approval Governor Ned Lamont announced Friday. The state had asked the federal government for 90.
The difference is not a footnote to the negotiation. It is the product of a federal policy change made seven weeks ago. On September 23, 2026, the Centers for Medicare & Medicaid Services published a six-page FAQ stating that, for "future approvals," it will cover up to 60 days of pre-release services in prisons, jails and adult tribal correctional facilities, down from the 90 days its own guidance had allowed since April 2023. Youth correctional facilities keep the 90-day window.
So Connecticut is not getting a smaller version of what other states won. It is getting the only version still on offer to adults.
What the approval covers
The federal benefit package is narrow, and CMS's FAQ sets a floor rather than a menu. States must cover, at minimum: case management that assesses physical and behavioral health needs and social determinants of health; medication-assisted treatment for all types of substance use disorder, as clinically appropriate, including counseling and behavioral therapy alongside the medication; and a 30-day supply of every prescription the person has at the time of release, handed over when they walk out.
To qualify, a person has to be Medicaid-eligible with an expected release date inside the window. States must offer outreach and enrollment help in every participating facility, and CMS is explicit that coverage is suspended during incarceration, not terminated — with application help early enough to use the full window.
The Department of Social Services leads as the state Medicaid agency, with the Department of Correction, DMHAS, DCF and the Judicial Branch's Court Support Services Division.
Correction Commissioner Sharonda Carlos put the scale in the announcement: about 12,000 adults and 650 adolescents are released from Connecticut's correctional facilities each year. State Senator Cathy Osten, co-chair of the Appropriations Committee, supplied the clinical case in her own statement — that one-third of incarcerated people in the state have active mental health disorders requiring ongoing treatment, and that 90% have a history of, or a current, substance use disorder.
The state's own paperwork still says 90 days
The DSS page describing the Justice-Involved Demonstration Waiver is still in its application-stage form. It says Connecticut asked for authority to cover services "90 days pre-release" for incarcerated adults and detained youth, and invites public comment to a state email address. As of Friday afternoon the page had not been updated to reflect the approval, or the shorter window.
Connecticut also does not yet appear on CMS's running list of approved reentry demonstrations, which as of Friday listed 23 jurisdictions — 22 states plus D.C. It included Washington, whose 90-day version this site covered in October, and five jurisdictions CMS approved in late September 2026, according to KFF: Louisiana, Maine, Minnesota, Nevada and D.C.
Federal lists lag announcements, so that part is routine. But the practical details — when coverage starts, which facilities go first, whether detained youth get the longer window — are not yet in any public document.
The second approval in the same letter
The reentry authority is the headline, but the announcement also reported something with more money attached: CMS stated that Connecticut will keep federal reimbursement for HUSKY members' residential and inpatient substance use treatment, in effect since April 2022.
That is the state's separate SUD demonstration, approved April 14, 2022 and effective through March 31, 2027. It is the authority that lets Medicaid pay for addiction treatment in facilities that would otherwise be excluded from payment as institutions for mental disease — residential and inpatient programs of more than 16 beds. Connecticut's application described it as covering the full ASAM continuum of care, from residential levels through withdrawal management, for adults and children.
In December 2025 the state filed for a five-year extension, April 2027 through March 2032, requesting no changes to the SUD portion beyond a technical correction to one eligibility group. A revised application followed in February 2026. Friday's announcement says federal reimbursement will continue; it does not say whether the extension was granted, and CMS had not posted an approval letter for it as of Friday afternoon.
For a family trying to place someone in residential treatment, this is the money that decides whether a bed is reimbursable.
What the state's own evaluation says about those beds
Connecticut has already had this authority for three and a half years, which means the state has data on what it bought. The mid-point assessment prepared by Mercer for the Connecticut Behavioral Health Partnership — dated February 2026 and updated in March — is the document to read alongside Friday's announcement. Its summary finding was blunt: the state "has completed most of the expected activities," but "many critical metrics are not moving in the direction of State targets, indicating that at this point in the Demonstration, activities have not translated into outcomes."
Two findings matter. The first is that residential and inpatient use did rise: from 4,525 people to 5,887, an increase of 30.1%, one of only two measures the evaluator recorded as moving in the intended direction. The second is that the supply of beds moved the other way. In the demonstration's second year, the report found, "the overall number of providers, and bed capacity have decreased," with provider concerns about "misalignment between rates and requirements" driving participating programs out.
The assessment also found no in-state Medicaid residential capacity for adolescents at all: the provider serving boys had closed, and stakeholders called current rates insufficient to keep such a facility open. Providers reported ongoing waitlists at ASAM level 3.1 and, to a lesser degree, 3.5, which means people either stay in a higher level of care they no longer need or step down too early. Consumer advocates, the evaluator wrote, "did not perceive increased access to care" and described access as getting worse.
Why the release window is the risk window
Connecticut's overdose picture is improving, which makes this the moment the plumbing matters more than the headline. Provisional federal counts put the state at 787 overdose deaths in the 12 months ending May 2026, down from 916 in the year ending May 2025 and 1,207 in the year ending May 2024. Deaths involving synthetic opioids other than methadone fell to 524.
Within that decline, the weeks after release remain the concentrated risk: tolerance drops during custody, a prescription lapses, and the first person offering a ride is often the first person offering a dose. The federal FAQ leans on exactly this literature — a 2022 study of Medicaid enrollees in eleven states on treatment duration and overdose risk, and a 2025 New England Journal of Medicine study of medications for opioid use disorder in county jails — to justify the 60 days.
Sixty days also assumes a release date exists 60 days out; people held on bail or released on a moving court date do not get that runway.
What happens next
Three requirements now hang over the Connecticut program. The state must submit a Reentry Initiative Implementation Plan describing how coverage will be operationalized, facility by facility, and a Reinvestment Plan: under the new terms, federal dollars that pay for services a correctional facility used to fund itself must be reinvested into allowable justice-related health activities, with annual progress reports and a final accounting. The mid-point assessment that produced the Mercer report is no longer required; a rapid-cycle report replaces it.
The larger uncertainty is budget neutrality. The 2025 reconciliation law wrote budget neutrality into statute and required the CMS Chief Actuary to certify demonstrations before approval, and KFF reported this week that June 2026 guidance implementing that change may reduce state flexibility, with rulemaking expected in early 2027. The same guidance phase-out covers health-related social needs services — the housing, transportation and food supports that Connecticut's own reentry amendment proposed to address. Whether a reentry benefit that is limited to case management, medication and a 30-day prescription supply can move outcomes in a state whose evaluator just found the bed base shrinking is the question the next assessment will answer.
For now, the concrete questions worth asking are unglamorous: when does billing start, which facilities are first, and does anyone leaving a Connecticut jail on a Tuesday night with a 30-day supply have somewhere to take the next prescription.
Where to get help
The SAMHSA National Helpline is 1-800-662-4357, free and available around the clock in English and Spanish. The 988 Suicide & Crisis Lifeline handles crisis calls and connects people to local services. Connecticut's 211 line can locate treatment and recovery supports in-state, and FindTreatment.gov lists Medicaid-accepting programs by ZIP code. Our guide to reentry from jail and prison covers the first 48 hours after release, and the Medicaid treatment guide explains what the coverage actually pays for once someone is enrolled.
Sources
- Office of Governor Ned Lamont — Governor Lamont Announces Federal Approval of Health Initiative for Justice-Involved Individuals (November 6, 2026)
- Connecticut Department of Social Services — 1115 Justice-Involved Demonstration Waiver
- Connecticut Department of Social Services — Section 1115 Demonstration Waiver for Substance Use Disorder (SUD) Treatment
- CMS — Reentry / Justice-Involved Section 1115 Demonstrations (approved state list)
- CMS — Frequently Asked Questions for Reentry Section 1115 Demonstrations (September 2026)
- Connecticut Behavioral Health Partnership / Mercer — Connecticut Substance Use Disorder Care 1115 Demonstration Mid-point Assessment (2026)
- KFF — 1115 Waiver Watch: A Look at Budget Neutrality Policy Changes (November 5, 2026)
- CDC National Center for Health Statistics — Provisional Drug Overdose Death Counts (VSRR)
- SAMHSA National Helpline
You might also read


